Resolute Wealth Strategies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,806
Closed -$219K 139
2026
Q1
$219K Buy
+7,806
New +$208K 0.09% 107
2024
Q3
Sell
-8,316
Closed -$233K 100
2024
Q2
$233K Sell
8,316
-116
-1% -$3.19K 0.13% 83
2024
Q1
$234K Sell
8,432
-1,312
-13% -$36.4K 0.14% 86
2023
Q4
$281K Sell
9,744
-116
-1% -$3.51K 0.19% 69
2023
Q3
$327K Buy
9,860
+81
+0.8% +$2.86K 0.24% 64
2023
Q2
$359K Buy
9,779
+74
+0.8% +$2.88K 0.28% 58
2023
Q1
$396K Buy
+9,705
New +$419K 0.34% 54

Other funds holding PFE

Resolute Wealth Strategies's PFE Position: Q2 2026 in Review

Resolute Wealth Strategies sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,806 shares — an estimated $219K sold.

Resolute Wealth Strategies first reported a position in PFE in Q1 2023 and held it in 7 quarters. The position peaked at $396K in Q1 2023. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Resolute Wealth Strategies reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Resolute Wealth Strategies sold 7,806 Pfizer shares in Q2 2026, an estimated $219K.
  • Resolute Wealth Strategies first reported a position in Pfizer in Q1 2023 and held it in 7 quarters.
  • Resolute Wealth Strategies's Pfizer position peaked at $396K in Q1 2023.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Resolute Wealth Strategies's 13F filing for Q2 2026, filed 12 Aug 2026.